Sinovac Biotech (NASDAQ:SVA) & Strongbridge Biopharma PLC (SBBP) Head to Head Analysis


Sinovac Biotech and Strongbridge Biopharma PLC are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitabiliy, analyst recommendations, dividends, earnings and institutional ownership. Sinovac Biotech has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.



from Biotech News